Núria Chic

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Francesco Schettini, Núria Chic, Fara Brasó‐Maristany et al. · npj Breast Cancer · 2021 · 691 citations · Full text

Medicine, Cancer Biology, Oncology +10

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Olga Martínez‐Sáez, Núria Chic, Tomás Pascual et al. · Breast Cancer Research · 2020 · 376 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

Aleix Prat, Cristina Saura, Tomás Pascual et al. · The Lancet Oncology · 2019 · 201 citations

Medicine, Oncology, Pharmacology +16

Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies

Anwesha Chaudhury, Nadia Solovieff, Laia Paré et al. · Journal of Clinical Oncology · 2021 · 153 citations · Full text

Medicine, Oncology, Pharmacology +17

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

Aleix Prat, Valentina Guarneri, Tomás Pascual et al. · EBioMedicine · 2022 · 145 citations · Full text

Medicine, Bioinformatics, Oncology +17